## Protocol Section
### Identification Module
**NCT ID:** NCT06432699

**Acronym:** MOPS

**Brief Title:** Rate of Canine Retraction and Pain Perception Following Micro-osteoperforation- a Split Mouth Clinical Study

**Official Title:** Rate of Canine Retraction and Pain Perception Following Micro-osteoperforation- a Split

#### Organization Study ID Info
**ID:** FF/FUMC/215-372Phy/23
#### Organization
**Class:** OTHER
**Full Name:** Foundation University Islamabad
### Status Module
#### Completion Date
**Date:** 2025-07

**Type:** ESTIMATED

#### Expanded Access Info
#### Last Update Post Date
**Date:** 2024-05-29

**Type:** ACTUAL

**Last Update Submit Date:** 2024-05-23

**Overall Status:** NOT_YET_RECRUITING

#### Primary Completion Date
**Date:** 2025-05

**Type:** ESTIMATED

#### Start Date
**Date:** 2024-05

**Type:** ESTIMATED

**Status Verified Date:** 2024-05

#### Study First Post Date
**Date:** 2024-05-29
**Type:** ACTUAL
**Study First Submit Date:** 2024-05-23
**Study First Submit QC Date:** 2024-05-23
### Sponsor Collaborators Module

#### Lead Sponsor

**Class:** OTHER

**Name:** Foundation University Islamabad

#### Responsible Party

**Investigator Affiliation:** Foundation University Islamabad

**Investigator Full Name:** Shoaib Rahim

**Investigator Title:** ZAINAB BUTT

**Type:** PRINCIPAL_INVESTIGATOR

### Oversight Module

**Is FDA Regulated Device:** False

**Is FDA Regulated Drug:** False

**Oversight Has DMC:** False

### Description Module

**Brief Summary:** DEFINITION: A short description of clinical study , including a brief statement of clinical study's hypothesis, written in language intended for the lay public Limit: 5000 CHARACTERS

**Detailed Description:** Definition: Extended description of the protocol ,including more technical information(as compared to the brief Summary), if desired. Do not include the entire protocol; do not duplicate information recorded in other data elements, such as eligibility criteria or outcome measures.

Limit:32,000 characters. For Patient Registries: Also describe the applicable registry procedures and other quality factors (for examples, third party certification, on site audit). In particular , summarize any procedures implemented as part of the patient registry, including , but not limited to the following:

* Quality assurance plan that addresses data validation and registry procedures, including and plans for site monitoring and auditing
* Data checks to compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry.
* Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources( for example, medical records, paper or electronic case reports forms, or interactive voice response systems)
* Data Dictionary that contains detailed descriptions of each variable used by the registry, including, including the source of the variable, coding information if used (for example World Health Organization Drug Dictionary, MedDRA), and normal ranges if relevant.
* STANDARD OPERATING PROCEDURE TO ADDRESS REGISTRY REGISTRY OPERATIONS AND ANALYSISACTIVITIES, SUCH AS PATIENT RECRUITMENT DATA COLLECTION,DATA MANAGEMENT., DATA ANALYSIS, reporting for adverse events, and change management.
* Sample Size Assessment to specify the number of participants or participate years necessary to demonstrate an effect.
* Plan for missing data to address situations where variable are reported a missing , unavailable non-reported, interpretable, or considered missing because of data inconsistency or out-of-range results.
* Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives , as specified in the study protocol or plan

### Conditions Module

**Conditions:**

- Pain

- Rate of Canine Retraction

**Keywords:**

- MOP

### Design Module

#### Design Info

**Allocation:** RANDOMIZED

**Intervention Model:** PARALLEL

**Intervention Model Description:** This is a single-blind, randomized parallel-arm study with two arms. Participants will be randomly assigned to either MOPS or no Mops

##### Masking Info

**Masking:** NONE

**Masking Description:** Participants will be randomly assigned to receive Micro-osteoperforation and the other side will be control.

**Primary Purpose:** SUPPORTIVE_CARE

#### Enrollment Info

**Count:** 60

**Type:** ESTIMATED

**Phases:**

- EARLY_PHASE1

**Study Type:** INTERVENTIONAL

### Arms Interventions Module

#### Arm Group 1

**Description:** Participants in this arm will receive no MOP treatment

**Label:** Control

**Type:** NO_INTERVENTION

#### Arm Group 2

**Description:** participants in this arm will receive MOPS intervention

**Intervention Names:**

- Other: micro osteoperforation

**Label:** Experimental

**Type:** EXPERIMENTAL

### Interventions

#### Intervention 1

**Arm Group Labels:**

- Experimental

**Description:** one side used for mops while other side will be control in same patient

**Name:** micro osteoperforation

**Other Names:**

- Placebo/Controlled

**Type:** OTHER

### Outcomes Module

#### Primary Outcomes

**Description:** patient after undergoing micro-osteoperforation will be aske to measure pain and check rate of canine retraction

**Measure:** pain will be measured after intervention of visual analogue scale

**Time Frame:** three months since the MOPS

### Eligibility Module

**Eligibility Criteria:** Inclusion Criteria:

- 1. Age range around 15-40 years. 2. Patients which have class I malocclusion or class II Div I malocclusion and include first premolar extraction as part of treatment plan..

3. No orthodontic treatment previously 4. Radiographic evidence showing no bone loss 5. History showing no periodontal disease. 6. History showing no systemic disease. 7. Probing depth less than 4 mm across the entire dentition 8. No active carious lesion or any sign of gingivitus

Exclusion Criteria:

1. Presence of any craniofacial abnormality.
2. Any history of bleeding disorders.
3. Poor oral hygiene.
4. Use of bisphosphonates, analgesics, anti-inflammatory drugs, corticosteroids for more than three months prior to treatment or during treatment.
5. Active diseases such as metabolic bone disease.
6. Malocclusions requiring surgical intervention.
7. Smoker

   -

**Healthy Volunteers:** True

**Maximum Age:** 40 Years

**Minimum Age:** 14 Years

**Sex:** ALL

**Standard Ages:**

- CHILD

- ADULT

### Contacts Locations Module

#### Central Contacts

**Contact 1:**

**Email:** rozina.nazir@fui.edu.pk

**Name:** Rozina Nazir, FCPS

**Phone:** +92 3215376612

**Role:** CONTACT

**Contact 2:**

**Email:** zainabbutt05@gmail.com

**Name:** zainab butt, BDS

**Phone:** +93225667847

**Role:** CONTACT

#### Locations

**Location 1:**

**City:** Islamabad

**Country:** Pakistan

**Facility:** Foundation University Islamabad

**State:** Punjab

**Zip:** 04403

### References Module

#### References

**Citation:** 1. Kundi, I., Alam, M. K., & Shaheed, S. (2020). Micro-osteo perforation effects as an intervention on canine retraction. The Saudi dental journal, 32(1), 15-20. https://doi.org/10.1016/j.sdentj.2019.05.009 2. Husain S, Sundari S. Comparison of the effectiveness of piezocision-aided canine retraction augmented with micro-osteoperforation: a randomized controlled trial. Angle Orthod. 2023 Oct 16. doi: 10.2319/052323-370.1. Epub ahead of print. PMID: 37839802. 12 3. Aboalnaga AA, Aboalnaga AA, Salah Fayed MM, El-Ashmawi NA, Soliman SA. Effect of micro-osteoperforation on the rate of canine retraction: a split- mouth randomized controlled trial. Prog Orthod. 2019 Jun;20(1) 21. doi:10.1186/s40510-019-0274-0. PMID: 31155698; PMCID: PMC6545296. 4. Bolat Gümüş, E., Kınsız, E. Effects of miniscrew-facilitated micro- osteoperforations on the rate of orthodontic tooth movement. J Orofac Orthop 84 (Suppl 2), 104-110 (2023). 5. Martina K., Kumar P., Misra V., Attri S., Yadav A., Sam R., Kumar R.. To evaluate the rate of canine retraction and pain perception following micro- osteoperforation - a split-mouth clinical study. Australasian Orthodontic Journal. 2022;38(2): 388-395

## Derived Section

### Condition Browse Module - Browse Branches

- Abbrev: BC23

- Name: Symptoms and General Pathology

- Abbrev: All

- Name: All Conditions

### Condition Browse Module - Browse Leaves

- ID: M13066

- Name: Pain

- Relevance: LOW

- As Found: Unknown

### Misc Info Module

- Version Holder: 2024-05-31
